Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsInterest & Investment IncomeNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $696.9 million.

  • Roivant Sciences' Shares Outstanding (Diluted Average) fell 471.18% to $696.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $696.9 million, marking a year-over-year decrease of 471.18%. This contributed to the annual value of $725.4 million for FY2025, which is 1271.33% down from last year.
  • Roivant Sciences' Shares Outstanding (Diluted Average) amounted to $696.9 million in Q4 2025, which was down 471.18% from $680.9 million recorded in Q3 2025.
  • Roivant Sciences' 5-year Shares Outstanding (Diluted Average) high stood at $844.5 million for Q4 2023, and its period low was $649.9 million during Q2 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $721.9 million, with a median of $712.8 million in 2023.
  • In the last 5 years, Roivant Sciences' Shares Outstanding (Diluted Average) skyrocketed by 1838.48% in 2023 and then tumbled by 1339.83% in 2024.
  • Over the past 5 years, Roivant Sciences' Shares Outstanding (Diluted Average) (Quarter) stood at $686.6 million in 2021, then grew by 3.89% to $713.3 million in 2022, then grew by 18.38% to $844.5 million in 2023, then decreased by 13.4% to $731.3 million in 2024, then fell by 4.71% to $696.9 million in 2025.
  • Its last three reported values are $696.9 million in Q4 2025, $680.9 million for Q3 2025, and $680.3 million during Q2 2025.